Clinical Trials Directory

Trials / Completed

CompletedNCT04666155

MOWOOT Device Treatment for Adults With Chronic Constipation

A Randomised Controlled Trial to Evaluate Effectiveness and Cost-Effectiveness of Intermittent Colonic Exoperistalsis Treatment With MOWOOT Medical Device in Adults With Chronic Constipation Using Trans-Anal Irrigation.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
86 (actual)
Sponsor
usMIMA S.L. · Industry
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to compare the effectiveness of the experimental Intermittent Colonic Exoperistalsis (ICE) treatment with MOWOOT, with the active control of trans-anal irrigation (TAI) as standard-of-care. The secondary objectives are to further compare the ICE treatment with MOWOOT to the TAI standard-of-care clinically and economically.

Detailed description

The RCT will assess clinical effectiveness by means of quantitative and qualitative variables, and the cost effectiveness by means of economic outcomes.

Conditions

Interventions

TypeNameDescription
DEVICEIntermittent Colonic Exoperistalsis with MOWOOT devicePatients under the experimental arm of the study should place the belt of the Mowoot device on the abdomen and use it for 20 minutes every day for 12 weeks. They should continue with their individualized standard of care againts constipation for the first 4 weeks. During the following 8 weeks of the interventional period of 12weeks, their use of SocTAI will be considered "rescue intervention". The 8weeks following the 12weeks of intervention, they can keep on using ICE device.or SocTAI or both.
DEVICEStandard of care with Trans-Anal IrrigationPatients under the active comparator arm of the study should continue with their individualized standard of care againts constipation for the 12weeks of intervention. The following 8 weeks they can keep on using SocTAI or ICE device or both.

Timeline

Start date
2024-04-25
Primary completion
2026-04-02
Completion
2026-04-02
First posted
2020-12-14
Last updated
2026-04-13

Locations

3 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04666155. Inclusion in this directory is not an endorsement.